检索结果-内蒙古大学图书馆

Update on the use of 45S5 bioactive glass in the treatment of bone defects in regenerative medicine

World Journal of Orthopedics 2024年第3期15卷 204-214页

作者： Dayane Maria Braz Nogueira Marcelie Priscila de Oliveira Rosso Daniela Vieira Buchaim Mariana Schutzer Ragghianti Zangrando Rogério Leone Buchaim Department of Prosthodontics and Periodontics Bauru School of DentistryUniversity of São PauloBauru 17012-901Brazil Department of Biological Sciences Bauru School of DentistryUniversity of São PauloBauru 17012-901Brazil Medical School University Center of AdamantinaAdamantina 17800-000Brazil Postgraduate Program in Structural and Functional Interactions in Rehabilitation Postgraduate DepartmentUniversity of MaríliaMarília 17525-902Brazil

Bone regeneration is a critical area in regenerative medicine,particularly in orthopedics,demanding effective biomedical materials for treating bone defects.45S5 bioactive glass(45S5 BG)is a promising material because of its osteoconductive and bioactive *** research in this field continues to advance,keeping up-to-date on the latest and most successful applications of this material is *** achieve this,we conducted a comprehensive search on Pub-Med/MEDLINE,focusing on English articles published in the last *** search used the keywords“bioglass 45S5 AND bone defect”in *** found 27 articles,and after applying the inclusion criteria,we selected 15 studies for detailed *** of these studies compared 45S5 BG with other cement or scaffold *** comparisons demonstrate that the addition of various composites enhances cellular biocompatibility,as evidenced by the cells and their osteogenic ***,the use of 45S5 BG is enhanced by its antimicrobial properties,opening avenues for additional investigations and applications of this biomaterial.

关键词： Biocompatible materials Bioglass Bone regeneration

来源：评论

学校读者我要写书评

暂无评论

Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk

引用

Clinical Practice and Research in Arteriosclerosis (English Edition) 2023年第5期35卷 236-242页

作者： Milla, Ana Maria Gonçalvez Chagas, Eduardo B.F. Miola, Vitor Fernando Bordin Zanuso, Bárbara de Oliveira Guiguer, Elen Landgraf Araújo, Adriano Cressoni Tofano, Ricardo José Quesada, Karina R. Laurindo, Lucas F. Barbalho, Sandra M. Postgraduate Program in Structural and Functional Interactions in Rehabilitation – UNIMAR Marília SP Brazil Department of Biochemistry and Pharmacology School of Medicine University of Marília (UNIMAR) Avenida Higino Muzzi Filho 1001 Marília São Paulo Brazil School of Food and Technology of Marilia (FATEC) Marilia SP Brazil

AbstractIntroductionThe lipid accumulation product (LAP) and visceral adipose index (VAI) are clinical markers of visceral obesity and were proposed as simple tools to estimate cardiovascular risk and mortality. The objective of this study was to analyze the accuracy of the VAI and LAP for high cardiovascular risk patients. MethodsA cross-sectional observational study of accuracy was carried out in 193 patients of both sexes. In addition to the variables VAI and LAP, presence of comorbidities, education, level of physical activity and anthropometric data were obtained. Cardiovascular risk was determined by the Framingham score. ResultsNo significant difference was observed in the sample in gender distribution (44.6% women; 55.4% men), 24.4% had low cardiovascular risk, 48.7% intermediate risk and 26.9% high cardiovascular risk. Linear regression analysis showed that VAI and LAP explain, respectively, only 2.4% and 5.2% of the variation in cardiovascular risk expressed by the Framingham score. The analysis of areas under the curve (AUC) for receiver operating characteristic (ROC) indicated a significant effect only of LAP to diagnose individuals with high cardiovascular risk, but with low sensitivity and specificity. ConclusionOur results indicate that VAI and LAP explain only a small percentage of the variation in the Framingham cardiovascular risk score. LAP index still deserves more attention in a cohort study, because, even with the limitations of a cross-sectional study, we observed an acceptable sensitivity for it so that the LAP can be used as a screening criterion for requesting more accurate tests.

关键词： Lipid accumulation product Visceral adipose index Obesity Cardiovascular risk Producto de acumulación de lípidos Índice de adiposidad visceral Obesidad Riesgo cardiovascular

来源：评论

学校读者我要写书评

暂无评论

Gene expression analysis of cytokines and MMPs in melatonin and rhBMP-2 enhanced bone remodeling

引用

World Journal of Orthopedics 2024年第11期15卷 1075-1087页

作者： Marina Ribeiro Paulini Letícia Ferreira Montarele Dimitrius Leonardo Pitol Gisele Giannocco Bruno Fiorelini Pereira Daniela Vieira Buchaim Carlos Henrique Bertoni Reis Rogério Leone Buchaim Joao Paulo Mardegan Issa Department of Basic and Oral Biology University of São PauloRibeirao Preto 14040-904Brazil Instituto de Ciências Ambientais Químicas e FarmacêuticasFederal University of São PauloDiadema 09972-270Brazil Medical School University Center of AdamantinaAdamantina 17800-000Brazil Postgraduate Program in Structural and Functional Interactions in Rehabilitation University of MariliaMarilia 17525-902Brazil Department of Biological Sciences Bauru School of DentistryUniversity of São PauloBauru 17012-901Brazil Department of Basic and Oral Biology Ribeirão Preto School of DentistryUniversity of São PauloRibeirao Preto 14040-904Brazil

BACKGROUND In the medical and dental fields,there is a need for studies of new therapeutic approaches for the treatment of bone defects that cause extensive bone *** may be an important endogenous biological factor for bone remodeling,and growth factors may enhance the repair *** To evaluate the gene expression of cytokines(IL-1β,IL-6,IL-10 and TNF-α),markers of osteoclastogenesis(RANK,RANKL and OPG)and MMPs(MMP-1,MMP-2,MMP-8 and MMP-13)from the treatment of melatonin associated with an osteogenic membrane and rhBMP-2 on the recovery of a bone *** Sixty-four rats were used and divided into 9 experimental groups and were formed according to the treatment carried out in the region of the bone lesion,which varied between the combination of 1,10 and 100μmol/L of *** Expression analysis was performed using real time-PCR by reading the concentration of total RNA and reverse *** There were differences between groups when compared with clot or scaffold control,and improvement with a higher concentration of melatonin or *** combination melatonin(1μg)with 5μg of rhBMP-2,using the guided bone regeneration technique,demonstrated some effects,albeit mild,on bone repair of critical bone *** This indicates that the approach for administering these substances needs to be reassessed,with the goal of ensuring their direct application to the affected ***,future research must be carried out,seeking to produce materials with these ideal characteristics.

关键词： Bone repair Melatonin Gene expression Rhbmp-2 Scaffold Tissue engineering Guided bone regeneration

来源：评论

学校读者我要写书评

暂无评论

Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification

引用

Molecular diagnosis & therapy 2025年 1-20页

作者： Mônica Duarte da Silva Thamires Santos da Silva Claudemir Gregório Mendes Maria Carolina Miglino Valbão Abraham Kwame Badu-Tawiah Lucas Fornari Laurindo Sandra Maria Barbalho Rosa Direito Maria Angélica Miglino Department of Chemistry and Biochemistry The Ohio State University Columbus OH USA. Graduate Program in Anatomy of Domestic and Wild Animals Faculty of Veterinary Medicine and Animal Science University of São Paulo (FMVZ/USP) São Paulo Brazil. Department of Biochemistry and Pharmacology School of Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil. Postgraduate Program in Structural and Functional Interactions in Rehabilitation School of Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil. Laboratory of Systems Integration Pharmacology Clinical and Regulatory Science Research Institute for Medicines Universidade de Lisboa (iMed.ULisboa) Lisbon Portugal. rdireito@ff.ulisboa.pt. Postgraduate Program in Animal Health Production and Environment School of Veterinary Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil. Department of Animal Anatomy School of Veterinary Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil.

Long coronavirus disease (COVID) is a multisystem condition that affects a significant proportion of individuals following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with persistent symptoms ranging from fatigue and cognitive dysfunction to cardiovascular disorders. It is estimated that 30-60% of infected individuals experience symptoms lasting more than 12 weeks. Despite advances in understanding acute infection, the pathophysiological mechanisms underlying long COVID remain unclear. Current hypotheses suggest that viral persistence, immune dysfunction, and metabolic alterations play central roles. Omics approaches, including metabolomics, proteomics, and lipidomics, have played a crucial role in investigating molecular changes, identifying biomarkers, and refining therapeutic strategies. This review discusses recent advances in understanding long COVID, addressing its mechanisms, risk factors, the impact of viral variants, and the role of vaccination, with an emphasis on the importance of omics technologies in elucidating this condition.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Lipid Accumulation Product: Reliable Marker for Cardiovascular Risk Detection?

引用

Open Journal of Epidemiology 2021年第3期11卷 267-277页

作者： Lidiane Aparecida Vila Pires Ricardo José Tofano Sandra Maria Barbalho Claudia Rucco Penteado Detregiachi Marcelo Dib Bechara Viviane Alessandra Capelluppi Tofano Jesselina Francisco dos Santos Haber Eduardo Federighi Baisi Chagas Ana Maria Gonçalvez Milla Karina Quesada School of Medicine University of Marília (UNIMAR) Marília S&#227 o Paulo Brazil Postgraduate Program in Structural and Functional Interactions in Rehabilitation University of Marilia (UNIMAR) S&#227 o Paulo Brazil Cardiology Unit of the UNIMAR Beneficent Hospital (HBU) Marilia S&#227 o Paulo Brazil Department of Biochemistry and Nutrition Faculty of Food Technology of Marília Marília S&#227 o Paulo Brazil CENID (Interdisciplinary Center on Diabetes)—UNIMAR—Marília S&#227 o Paulo Brazil

The Lipid Accumulation Product (LAP) is a clinical marker of visceral obesity and has been proposed as a simple, inexpensive, and accurate tool to estimate cardiovascular risk and mortality. The aim of this study was to verify the association of LAP with anthropometric, biochemical, visceral adiposity index and IR in adults and the elderly. This single cross-section center clinical study, with experimental, analytical, primary, and observational design, included 210 participants. Anthropometric (Body Mass Index (BMI), Waist Circumference (WC), and Neck Circumference (NC)), LAP, Visceral Adipose Index (VAI), and biochemical parameters (fasting glycemia, insulinemia (to calculate the Homa-IR index), total cholesterol, LDL-c, HDL-c, and triglycerides) were evaluated. The results showed that by separating the sample into three groups (adequate BMI and WC, adequate BMI and elevated WC, and elevated BMI and WC), the group with high BMI and WC showed a high value of LAP and VAI compared to the other groups, with a significant difference. Still, the data show a positive and significant correlation when relating the LAP with VAI, HOMA-IR, BMI, WC, NC, total cholesterol, triglycerides, and Diastolic Blood Pressure. It also showed an inversely proportional relationship when associating LAP with HDL-c (p < 0.0001). Thus, we show that LAP is closely related to visceral adiposity, IR, altered lipid parameters, and blood pressure, especially diastolic in the patients included in our study. For these reasons, we suggest that LAP is a reliable indicator of promising visceral adiposity for early detection of cardiovascular risk in the adult and senior population.

关键词： Lipid Accumulation Product Obesity. Visceral Obesity Metabolic Syndrome Cardiovascular Risk

来源：评论

学校读者我要写书评

暂无评论

COVID-19 and Gestational Diabetes: A Systematic Review

引用

Journal of Diabetes Mellitus 2020年第4期10卷 236-244页

作者： Vitor Fernando Bordin Miola Ana Rita de Oliveira dos Santos Bárbara de Oliveira Zanuso Maria Eduarda Guelfi Pinto João Paulo Galleti Pillon Jesselina Francisco dos Santos Haber Ricardo de Alvares Goulart Sandra Maria Barbalho Department of Biochemistry and Pharmacology School of Medicine University of Marília (UNIMAR) S&atildeo Paulo Brazil Postgraduate Program in Structural and Functional Interactions in Rehabilitation University of Marilia (UNIMAR) S&atildeo Paulo Brazil Department of Biochemistry and Nutrition Faculty of Food Technology of Marília S&atildeo Paulo Brazil

In March 2020, the World Health Organization declared a pandemic state in response to the number of infected and killed by COVID-19. Gestational diabetes (GD) is characterized by physiological changes making pregnant women even more vulnerable to viral respiratory infections, such as SARS-CoV-2. For these reasons and due to the restriction of data related to DMG and the involvement by COVID-19, the importance of raising information about these two conditions is evident. Therefore, this study aimed to perform a literature review about the complications of COVID-19 in patients with GD. MEDLINE-PubMed, EMBASE, and Scielo databases were searched and followed the PRISMA guidelines. Only four studies were included in the systematic review. The complications and mortality are more significant in pregnant women with diabetes since hyperglycemia promotes immune changes in the inflammatory state and worsens insulin resistance. The imbalance in the immune response favors the development of infections, the most likely being viral respiratory infections. On the other hand, other studies show insufficient recent evidence to indicate that pregnant women are more susceptible to infection with severe acute coronavirus respiratory syndrome. There are divergences between studies concerning complications related to COVID-19 in patients with GD. In view of this scenario and from the information obtained, it is noted that the literature is scarce regarding the worsening of COVID-19 in patients with GD. Therefore, it is necessary to continue research on these mechanisms that may justify their correlation.

关键词： COVID-19 Diabetes Mellitus Gestational Diabetes Hyperglycemia

来源：评论

学校读者我要写书评

暂无评论

Corrigendum to "Pomegranate (Punica granatum L.) phytochemicals target the components of metabolic syndrome" [Journal of Nutritional Biochemistry 131 (2024) 109670]

引用

The Journal of nutritional biochemistry 2025年 136卷 109793页

作者： Lucas Fornari Laurindo Victória Dogani Rodrigues Giulia Minniti Antonelly Cassio Alves de Carvalho Tereza Laís Menegucci Zutin Lindsay K DeLiberto Anupam Bishayee Sandra Maria Barbalho Department of Biochemistry and Pharmacology School of Medicine Faculdade de Medicina de Marília (FAMEMA) Marília São Paulo Brazil Department of Biochemistry and Pharmacology School of Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil. Department of Biochemistry and Pharmacology School of Medicine Faculdade de Medicina de Marília (FAMEMA) Marília São Paulo Brazil. Postgraduate Program in Structural and Functional Interactions in Rehabilitation Universidade de Marília (UNIMAR) Marília São Paulo Brazil. Department of Biochemistry and Pharmacology School of Medicine Universidade de Marília (UNIMAR) Marília São Paulo Brazil Department of Pharmacology College of Osteopathic Medicine Lake Erie College of Osteopathic Medicine Bradenton FL USA. Department of Pharmacology College of Osteopathic Medicine Lake Erie College of Osteopathic Medicine Bradenton FL USA. Electronic address: abishayee@lecom.edu. Postgraduate Program in Structural and Functional Interactions in Rehabilitation Universidade de Marília (UNIMAR) Marília São Paulo Brazil Department of Biochemistry and Nutrition School of Food and Technology of Marília (FATEC) São Paulo Marília Brazil. Electronic address: smbarbalho@***.

来源：评论

学校读者我要写书评

暂无评论

Corrigendum to Peanut (Arachis hypogaea L.) seeds and by-products in metabolic syndrome and cardiovascular disorders: A systematic review of clinical studies Phytomedicine 123 (2024) 155170

引用

Phytomedicine : international journal of phytotherapy and phytopharmacology 2025年 136卷 155870页

作者： Yandra Cervelim Nunes Gian de Oliveira Santos Nathália Mendes Machado Alda M M B Otoboni Lucas Fornari Laurindo Anusha Bishayee Carmela Fimognari Anupam Bishayee Sandra Maria Barbalho Department of Biochemistry and Nutrition School of Food and Technology of Marília (FATEC) Marília 17500-000 São Paulo Brazil. Department of Biochemistry and Pharmacology School of Medicine University of Marília (UNIMAR) Marília 17525-902 São Paulo Brazil. Department of Biochemistry and Pharmacology School of Medicine Faculdade de Medicina de Marília (FAMEMA) Marília 17519-030 São Paulo Brazil. Department of Statistics and Data Science College of Arts and Sciences Cornell University Ithaca NY 14850 USA. Department for Life Quality Studies University of Bologna 47921 Rimini Italy. College of Osteopathic Medicine Lake Erie College of Osteopathic Medicine Bradenton FL 34211 USA. Electronic address: abishayee@lecom.edu. Department of Biochemistry and Nutrition School of Food and Technology of Marília (FATEC) Marília 17500-000 São Paulo Brazil Department of Biochemistry and Pharmacology School of Medicine University of Marília (UNIMAR) Marília 17525-902 São Paulo Brazil Postgraduate Program in Structural and Functional Interactions in Rehabilitation University of Marília (UNIMAR) Marília 17525-902 São Paulo Brazil. Electronic address: smbarbalho@***.

BACKGROUND:Cardiovascular diseases (CVDs) are the leading causes of death worldwide. The main risk factors are hypertension, diabetes, obesity, and increased serum lipids. The peanut (Arachis hypogaea L.), also known as the groundnut, goober, pindar, or monkey nut, belongs to the Fabaceae family and is the fourth most cultivated oilseed in the world. The seeds and skin of peanuts possess a rich phytochemical profile composed of antioxidants, such as phenolic acids, stilbenes, flavonoids, and phytosterols. Peanut consumption can provide numerous health benefits, such as anti-obesity, antidiabetic, antihypertensive, and hypolipidemic effects. Accordingly, peanuts have the potential to treat CVD and counteract its risk factors. PURPOSE:This study aims to critically evaluate the effects of peanuts on metabolic syndrome (MetS) and CVD risk factors based on clinical studies. METHOD:This review includes studies indexed in MEDLINE-PubMed, COCHRANE, and EMBASE, and the Preferred Reporting Items for a Systematic Review and Meta-Analysis guidelines were adhered to. RESULTS:Nineteen studies were included and indicated that the consumption of raw peanuts or differing forms of processed foods containing peanut products and phytochemicals could improve metabolic parameters, such as glycemia, insulinemia, glycated hemoglobin, lipids, body mass index, waist circumference, atherogenic indices, and endothelial function. CONCLUSION:We propose that this legume and its products be used as a sustainable and low-cost alternative for the prevention and treatment of MetS and CVD. However, further research with larger sample sizes, longer intervention durations, and more diverse populations is needed to understand the full benefit of peanut consumption in MetS and CVD.

关键词： Arachis hypogaea peanuts, diabetes, obesity, hypertension, metabolic syndrome, cardiovascular disease

来源：评论

学校读者我要写书评

暂无评论

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

引用

eClinicalMedicine 2023年 64卷 102193-102193页

作者： Wu, Dongze Jin, Yingzhao Xing, Yuhan Abate, Melsew Dagne Abbasian, Mohammadreza Abbasi-Kangevari, Mohsen Abbasi-Kangevari, Zeinab Abd-Allah, Foad Abdelmasseh, Michael Abdollahifar, Mohammad-Amin Abdulah, Deldar Morad Abedi, Aidin Abedi, Vida Abidi, Hassan Aboagye, Richard Gyan Abolhassani, Hassan Abuabara, Katrina Abyadeh, Morteza Addo, Isaac Yeboah Adeniji, Kayode Nelson Adepoju, Abiola Victor Adesina, Miracle Ayomikun Adnani, Qorinah Estiningtyas Sakilah Afarideh, Mohsen Aghamiri, Shahin Agodi, Antonella Agrawal, Anurag Arriagada, Constanza Elizabeth Aguilera Ahmad, Aqeel Ahmad, Danish Ahmad, Sohail Ahmadi, Ali Ahmed, Ayman Aithala, Janardhana P. Ajadi, Abdullateef Abiodun Ajami, Marjan Akbarzadeh-Khiavi, Mostafa Alahdab, Fares AlBataineh, Mohammad T. Alemi, Sharifullah Al-Gheethi, Adel Ali Saeed Ali, Liaqat Alif, Sheikh Mohammad Almazan, Joseph Uy Almustanyir, Sami Alqahtani, Jaber S. Alqasmi, Ibrahim Altaf, Ihsan Ullah Khan Alvis-Guzman, Nelson Alvis-Zakzuk, Nelson J. Al-Worafi, Yaser Mohammed Aly, Hany Amani, Reza Amu, Hubert Amusa, Ganiyu Adeniyi Andrei, Catalina Liliana Ansar, Adnan Ansariniya, Hossein Anyasodor, Anayochukwu Edward Arabloo, Jalal Arefnezhad, Reza Arulappan, Judie Asghari-Jafarabadi, Mohammad Ashraf, Tahira Atata, Jamila Abdulhamid Athari, Seyyed Shamsadin Atlaw, Daniel Atout, Maha Moh'd Wahbi Aujayeb, Avinash Awan, Asma Tahir Ayatollahi, Haleh Azadnajafabad, Sina Azzam, Ahmed Y. Badawi, Alaa Badiye, Ashish D. Bagherieh, Sara Baig, Atif Amin Bantie, Berihun Bantie Barchitta, Martina Bardhan, Mainak Barker-Collo, Suzanne Lyn Barone-Adesi, Francesco Batra, Kavita Bayileyegn, Nebiyou Simegnew Behnoush, Amir Hossein Belgaumi, Uzma Iqbal Bemanalizadeh, Maryam Bensenor, Isabela M. Beyene, Kebede A. Bhagavathula, Akshaya Srikanth Bhardwaj, Pankaj Bhaskar, Sonu Bhat, Ajay Nagesh Bitaraf, Saeid Bitra, Veera R. Boloor, Archith Bora, Kaustubh Botelho, João Silva Buchbinder, Rachelle Calina, Daniela Cámera, Luis Alberto Carvalho, Andre F. Chan, Jeffrey Shi Kai Chattu, Vijay Kumar Abebe, Endeshaw Chekol Department of Rheumatology and Immunology Sichuan Provincial People's Hospital School of Medicine University of Electronic Science and Technology of China China Department of Medicine & Therapeutics The Chinese University of Hong Kong Hong Kong Department of Paediatrics The Chinese University of Hong Kong Hong Kong School of Pharmacy The Chinese University of Hong Kong Hong Kong Jockey Club School of Public Health and Primary Care The Chinese University of Hong Kong Hong Kong Department of Nursing Woldia University Woldia Ethiopia Department of Orthopedic Surgery Harvard University Boston MA United States Postgraduate Medical Education Harvard University Boston MA United States Maternal Fetal Care Center Harvard University Boston MA United States Department of Health Policy and Oral Epidemiology Harvard University Boston MA United States Division of General Internal Medicine Harvard University Boston MA United States Department of Orthopaedic Surgery Shahid Beheshti University of Medical Sciences Tehran Iran Social Determinants of Health Research Center Shahid Beheshti University of Medical Sciences Tehran Iran Department of Biotechnology Shahid Beheshti University of Medical Sciences Tehran Iran Department of Epidemiology Shahid Beheshti University of Medical Sciences Tehran Iran National Nutrition and Food Technology Research Institute Shahid Beheshti University of Medical Sciences Tehran Iran Department of Immunology Shahid Beheshti University of Medical Sciences Tehran Iran Department of Neurology Shahid Beheshti University of Medical Sciences Tehran Iran Department of Medical Genetics Shahid Beheshti University of Medical Sciences Tehran Iran Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences Tehran Iran Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran Department of Health Economics and Statistics Shahid Beheshti University of Medical Sciences Tehran Iran Functional Neuro

Background: The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019. Methods: We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends. Findings: In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR. Interpretation: The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rh

关键词： Global burden of disease study Immune-mediated inflammatory disease Incidence Trend

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：